Spatial Code of Tumors: Mapping, Modeling, and Mechanism
One of 1,906 projects Taiyo tracks in Israel.
Source: EU Funding & Tenders Portal
Tumors are ecosystems, where malignant and non-malignant cells interact within an organized tumor microenvironment (TME). Understanding how these interactions drive complex pathology such as metastasis and response to treatment is a major challenge in cancer biology. While spatial proteomics technologies have begun to reveal the architectural complexity of human tumors, current approaches are limi
- Status
- Prospective
- Location
- Israel
- Updated
- 19 Nov 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about Spatial Code of Tumors: Mapping, Modeling, and Mechanism
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | forthcoming |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | Tumors are ecosystems, where malignant and non-malignant cells interact within an organized tumor microenvironment (TME). Understanding how these interactions drive complex pathology such as metastasis and response to treatment is a major challenge in cancer biology. While spatial proteomics technologies have begun to reveal the architectural complexity of human tumors, current approaches are limited in scale, standardization, and functional interpretability. Existing platforms measure only dozens of proteins, analysis pipelines are fragmented, hindering cross-cohort integration, and functional studies rarely preserve the TME’s architecture. This project addresses the question: what are the spatially organized intercellular networks that govern therapeutic response and resistance in human tumors. To answer it, it proposes three interconnected aims to develop new technologies to map such networks at scale, interrogate them using a common modeling framework and perform mechanistic studies to elucidate their function. In Aim 1, we will develop KiloPlex, a novel spatial proteomics method to image 1000 proteins in intact human tumors using combinatorial staining and AI-based decomposition. We will apply KiloPlex to profile 1000 tumors from 10 cancer types, generating a comprehensive spatial proteomics atlas with unprecedented molecular resolution. In Aim 2, we will build an AI foundation model trained on this data and existing data to enable generalizable analysis of tissue organization and cell-cell interactions across cancer types. In Aim 3, we will couple spatial proteomics with ex vivo cultures to perturb and probe tumor-related immune populations and drug-targeted T cells, to understand their function in mediating response to checkpoint inhibitors. Together, these aims will establish a new framework for spatially resolved, functional tumor profiling, opening the door to informed biomarkers, therapeutic targets, and precision immunotherapy strategies. |
Location
Country | Israel |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Article published date | 2026-10-15 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
